No Chemo Benefit in Older Women With High-Risk HR-Positive Breast Cancer

(MedPage Today) — Older women with genomically high-risk hormone receptor (HR)-positive breast cancer did not benefit from adjuvant chemotherapy, which caused a high rate of severe toxicity, according to a large randomized trial.
Overall survival…